相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comment on Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
Haitang Yang et al.
BRITISH JOURNAL OF CANCER (2021)
Response to Comment on Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
Michael G. White et al.
BRITISH JOURNAL OF CANCER (2021)
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis
Roberta Carosio et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival
Carla Chiarucci et al.
CANCERS (2020)
Antiangiogeneic Strategies in Mesothelioma
Anna K. Nowak et al.
FRONTIERS IN ONCOLOGY (2020)
Immunotherapy in Malignant Pleural Mesothelioma
Cornedine J. de Gooijer et al.
FRONTIERS IN ONCOLOGY (2020)
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Isabelle Opitz et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2020)
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Arnaud Scherpereel et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition
Bahil Ghanim et al.
SCIENTIFIC REPORTS (2020)
Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis
Alvaro Lopez-Janeiro et al.
MODERN PATHOLOGY (2020)
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
Thibaut Blondy et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Should Lung-Sparing Surgery Be the Standard Procedure for Malignant Pleural Mesothelioma?
Yoshinobu Ichiki et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma
Haitang Yang et al.
CANCERS (2020)
TGF-β Mediated Immune Evasion in Cancer-Spotlight on Cancer-Associated Fibroblasts
Parisa Ghahremanifard et al.
CANCERS (2020)
Iron: An Essential Element of Cancer Metabolism
Myriam Y. Hsu et al.
CELLS (2020)
Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
Haitang Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Preoperative Identification of Benefit from Surgery for Malignant Pleural Mesothelioma
Isabelle Opitz et al.
THORACIC SURGERY CLINICS (2020)
PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study
Liu Jin et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis
Qinfen Xie et al.
DOSE-RESPONSE (2020)
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
Da Hyun Kang et al.
IMMUNE NETWORK (2020)
Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer
Yi Zhang et al.
CLINICS (2020)
Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis
Wei Zhang et al.
JOURNAL OF CANCER (2020)
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Giuseppe Badalamenti et al.
CELLULAR IMMUNOLOGY (2019)
Celecoxib in Cancer Therapy and Prevention - Review
Natalia Toloczko-Iwaniuk et al.
CURRENT DRUG TARGETS (2019)
C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer
Kensuke Kudou et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery
Edward J. A. Harris et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Serum Levels of Prealbumin and Albumin for Preoperative Risk Stratification
Tyler J. Loftus et al.
NUTRITION IN CLINICAL PRACTICE (2019)
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort
Solenn Brosseau et al.
CLINICAL LUNG CANCER (2019)
The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma
Wenjie Yin et al.
ONCOLOGY RESEARCH AND TREATMENT (2019)
Prognostic role of C-reactive protein to albumin ratio in colorectal cancer A meta analysis
Fan Wang et al.
MEDICINE (2019)
Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer A systematic review and meta-analysis
Menglei Li et al.
MEDICINE (2019)
Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity
Gregor Vlacic et al.
CELLS (2019)
Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis
Zhenhua Liu et al.
BMC CANCER (2019)
Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients A meta-analysis
Fei Cheng et al.
MEDICINE (2019)
Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
Takumi Kishimoto et al.
BMC CANCER (2019)
Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention
Shinya Toyokuni
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Cyclooxygenase-2 in cancer: A review
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Contribution of regulatory T cells to cancer: A review
Masoud Najafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma Phase 1b Results From the JAVELIN Solid Tumor Trial
Raffit Hassan et al.
JAMA ONCOLOGY (2019)
The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
Gerard J. Chu et al.
FRONTIERS IN ONCOLOGY (2019)
Comparison of serum biochemical markers in patients with mesothelioma and pleural plaques versus healthy individuals exposed to environmental asbestos
Isa Dongel et al.
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
Serum albumin in patients undergoing transcatheter aortic valve replacement: A meta-analysis
Wan Chin Hsieh et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2019)
The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer
Jia Li Low et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Prognostic value of PD-L1 expression in patients with primary solid tumors
Xiao Xiang et al.
ONCOTARGET (2018)
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
Emerson Y. Chen et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time
G. Pasello et al.
ANNALS OF ONCOLOGY (2018)
The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study
Shinkichi Takamori et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats
Yuuki Ohara et al.
CANCER SCIENCE (2018)
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal
Karin Schelch et al.
CARCINOGENESIS (2018)
Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis
Bo Li et al.
CLINICA CHIMICA ACTA (2018)
Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis
Aleksandra Semeniuk-Wojtas et al.
CLINICAL GENITOURINARY CANCER (2018)
Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma
Shingo Inaguma et al.
HUMAN PATHOLOGY (2018)
Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma
Jorien Minnema-Luiting et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma
Josine Quispel-Janssen et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
Tatsunori Kiriu et al.
PLOS ONE (2018)
Prognostic and diagnostic impact of fibrinogen, neutrophil-tolymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome
Stefan Janik et al.
Oncotarget (2018)
Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
Noomi Vainer et al.
Oncotarget (2018)
Surgery for malignant pleural mesothelioma: an international guidelines review
Sara Ricciardi et al.
JOURNAL OF THORACIC DISEASE (2018)
Low preoperative serum prealbumin levels and the postoperative surgical site infection risk in elective spine surgery: a consecutive series
David J. Salvetti et al.
JOURNAL OF NEUROSURGERY-SPINE (2018)
Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer
Yijun Jia et al.
LUNG CANCER (2018)
Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer
Lilan Yi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis
Yan Lin et al.
EJSO (2018)
The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer
Tai-Bing Deng et al.
MEDICINE (2018)
The role of celecoxib for colorectal cancer treatment: a systematic review
Xiaohan Zhou et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma
Takehiro Otoshi et al.
IN VIVO (2018)
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
Elly Marcq et al.
ONCOIMMUNOLOGY (2017)
Hyperferritinemia and inflammation
Kate F. Kernan et al.
INTERNATIONAL IMMUNOLOGY (2017)
The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review
Abdelhamed Haram et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
Evan W. Alley et al.
LANCET ONCOLOGY (2017)
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem et al.
LUNG CANCER (2017)
Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer
Jukka Kallio et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer
Yuta Ibuki et al.
WORLD JOURNAL OF SURGERY (2017)
Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis
Stefan Janik et al.
ONCOTARGET (2017)
Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis
Randy C. Bowen et al.
ONCOTARGET (2017)
Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies
Nan Chen et al.
Oncotarget (2017)
Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma
Thomas Klikovits et al.
SCIENTIFIC REPORTS (2017)
Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth
Chiara Agostinis et al.
FRONTIERS IN IMMUNOLOGY (2017)
Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma
Kazuma Kiyotani et al.
ONCOIMMUNOLOGY (2017)
Novel insights into mesothelioma biology and implications for therapy
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2017)
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
Yubo Liu et al.
BMC CANCER (2017)
Elevated aspartate aminotransferase and monocyte counts predict unfavorable prognosis in patients with malignant pleural mesothelioma
A. Zhang et al.
NEOPLASMA (2017)
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
Josee-Lyne Ethier et al.
BREAST CANCER RESEARCH (2017)
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis
Hariruk Yodying et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study
Mir Alireza Hoda et al.
EUROPEAN JOURNAL OF CANCER (2016)
The beneficial effect of acute phase increase in serum ferritin
Jecko Thachil
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages
Anne-Laure Chene et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis
Fraser J. H. Brims et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma
Andrea Bille et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
Gerard Zalcman et al.
LANCET (2016)
Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis
Liangyou Gu et al.
ONCOTARGET (2016)
Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis
Hua Zhang et al.
SCIENTIFIC REPORTS (2016)
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors
Mark M. Awad et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma
Alberto Sandri et al.
JOURNAL OF THORACIC DISEASE (2016)
Prognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma
Abdullah Cetin Tanrikulu et al.
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2016)
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
B. Ghanim et al.
BRITISH JOURNAL OF CANCER (2015)
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis
C. Perisanidis et al.
CANCER TREATMENT REVIEWS (2015)
A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma A Review of 12 Years' Experience
Isabelle Opitz et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma
Robin Cornelissen et al.
LUNG CANCER (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer
Bahil Ghanim et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2015)
Is low serum albumin associated with postoperative complications in patients undergoing cardiac surgery?
Pamela L. Karas et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2015)
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies
Angela Bononi et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2015)
The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers
Hideki Ujiie et al.
ONCOIMMUNOLOGY (2015)
Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
Susana Cedres et al.
PLOS ONE (2015)
Fibroblast Growth Factor Receptor Inhibition Is Active against Mesothelioma and Synergizes with Radio- and Chemotherapy
Karin Schelch et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
B. Ghanim et al.
BRITISH JOURNAL OF CANCER (2014)
Evaluation of Malnutrition in Orthopaedic Surgery
Michael Brian Cross et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2014)
B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis
Aaron Scott Mansfield et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
Cleo Robinson et al.
LUNG CANCER (2014)
Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma
Robin Cornelissen et al.
PLOS ONE (2014)
Oxidative Status and Acute Phase Reactants in Patients with Environmental Asbestos Exposure and Mesothelioma
Cengizhan Sezgi et al.
SCIENTIFIC WORLD JOURNAL (2014)
Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma
Zhou-Hong Yao et al.
TUMOR BIOLOGY (2014)
Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer
C. Zielinski et al.
ANNALS OF ONCOLOGY (2013)
Prognostic Role of C-reactive Protein in Gastric Cancer: A Meta-analysis
Qing Yu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
T. M. Meniawy et al.
BRITISH JOURNAL OF CANCER (2013)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
Molecular pathogenesis of malignant mesothelioma
Yoshitaka Sekido
CARCINOGENESIS (2013)
Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
Chin Hao Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis
Mariette Baud et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
Miao-Fen Chen et al.
MOLECULAR CANCER (2013)
Cyclooxygenase-2, Epidermal Growth Factor Receptor, and Aromatase Signaling in Inflammation and Mesothelioma
Barbara Nuvoli et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer
Wenwei Hao et al.
MEDICAL ONCOLOGY (2013)
C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients
Otavio T. Ranzani et al.
PLOS ONE (2013)
Health-related quality of life and inflammatory markers in malignant pleural mesothelioma
Steven C. Kao et al.
SUPPORTIVE CARE IN CANCER (2013)
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
Annelyse Duvoix et al.
THORAX (2013)
Pretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma A Retrospective Multicenter Analysis
Bahil Ghanim et al.
ANNALS OF SURGERY (2012)
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells
M. A. Hoda et al.
BRITISH JOURNAL OF CANCER (2012)
Iron overload signature in chrysotile-induced malignant mesothelioma
Li Jiang et al.
JOURNAL OF PATHOLOGY (2012)
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
David James Pinato et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions
Christophe Blanquart et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601) A Brief Report
Arkadiusz Z. Dudek et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine
Steven Chuan-Hao Kao et al.
LUNG CANCER (2012)
Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network
Qi Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma
Fabien Gueugnon et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Circulating and Tumor-Infiltrating Myeloid Cells Predict Survival in Human Pleural Mesothelioma
Bryan M. Burt et al.
CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Survival and Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Study of 314 patients in the West Part of Japan
Shuko Nojiri et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy
Steven Chuan-Hao Kao et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Predictive biomarkers: a paradigm shift towards personalized cancer medicine
Nicholas B. La Thangue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
Joris D. Veltman et al.
BMC CANCER (2010)
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial
V. Seebacher et al.
BRITISH JOURNAL OF CANCER (2010)
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection
Noriyuki Yamada et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
Steven C. H. Kao et al.
CLINICAL CANCER RESEARCH (2010)
May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
Tommaso Claudio Mineo et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Elevated Preoperative C-reactive Protein Predicts Poor Cancer Specific Survival in Patients Undergoing Resection for Non-small Cell Lung Cancer
Caroline O'Dowd et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Digant Gupta et al.
NUTRITION JOURNAL (2010)
Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome
Emily Fairclough et al.
CLINICAL MEDICINE (2009)
Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma
Masaki Anraku et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas
Yasuo Adachi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses
J. P. J. J. Hegmans et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma
SL O'Kane et al.
EUROPEAN JOURNAL OF CANCER (2005)
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials
DA Fennell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention
A Catalano et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
C-reactive protein
S Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma
A Baldi et al.
THORAX (2004)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
T Bachelot et al.
BRITISH JOURNAL OF CANCER (2003)
C-reactive protein: a critical update
MB Pepys et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Angiogenesis is an independent prognostic factor in malignant mesothelioma
JG Edwards et al.
BRITISH JOURNAL OF CANCER (2001)
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
L Strizzi et al.
JOURNAL OF PATHOLOGY (2001)
Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems
JG Edwards et al.
THORAX (2000)
分享论文
